Dear Members,
Hope you are doing well.
We are glad to inform you that we have completed 6 years of running Alpha and Alpha + Tracker Sheets.
As you might be aware, we started maintaining tracker sheets with a hypothetical sum of Rs 50 lakhs on 15th Aug’18.
The main purpose of the same was to create something for the members to show them how we would act based on our research. Also, to determine performance of our research analysis on portfolio basis than on individual stock basis.
Since 15th Aug’18, we haven’t added any capital to the same, except for dividends.
On 15th Aug’24, Alpha + Tracker’s value was Rs 2.05 crore.
From Aug’18 till Mar’20, it was a tough period as the small and mid-caps went through a phase of correction.
In fact, at one point of time, the 50 lakhs sum was down to around Rs 31 lakhs in Mar’20. We were barely matching Nifty Midcap 100 in terms of performance and underperforming NIFTY 50.
Since Mar’20, the market has been kind, and we are glad that tracker sheets have done reasonably well.
As we keep saying, you can’t have all the winning stocks in your portfolio; however, with adequate diversification, over longer term market rewards you through – Asymmetric Payoffs.
In the long term, stocks can go up 2x, 5x, 10x or much higher while the max you can lose on a stock is 100%.
Our experience has been, if the research is good, out of 10 stocks, 2-3 will surely go wrong. But the gains from the winners can be far higher than the losses from the bad ones.
And we have already witnessed that with stocks like Carysil, Aarti Drugs, 20 Microns, Time Technoplast, LT Foods, Vadilal Industries, Control Print, Suven Pharma, etc. delivering much higher returns in comparison to losses on the stocks like Shemaroo, Valiant, Tiger Logistics, Mirza International, Bajaj Consumer, etc.
Going forward, while we don’t know as to how long the markets will continue moving up, one thing is sure, market movements tend to by cyclical and just like 2018-20, there will be periods of correction.
The intensity, duration can vary, but eventually, there will be a down cycle.
While one cannot always remain unimpacted by corrections, we hope to limit the downside by focusing on growth stocks available at reasonable valuations, cyclical opportunities and special situation opportunities.
Disclosure: Out of the stocks under coverage, I have personal investment in Manappuram Finance, Carysil, Shemaroo, Fiem Industries, Insecticides India, Shree Pushkar, Kaveri Seed, LT Foods, Dollar Industries, Sharda Cropchem, Time Technoplast, IOLCP, Chaman Lal Setia, Ultramarine Pigments, 20 Microns, Valiant Organics and Repco Home Finance.
Best Regards,
Ekansh Mittal
Research Analyst
https://www.katalystwealth.com/
Ph.: +91-727-5050062, Mob: +91-9818866676
Email: [email protected]
By subscribing to Alpha/Alpha Plus, you agree to accept the following terms/conditions:
www.katalystwealth.com (here in referred to as Katalyst Wealth) is the domain owned by Ekansh Mittal. Mr. Ekansh Mittal is the sole proprietor of Mittal Consulting and offers independent equity research services to investors on subscription basis. SEBI (Research Analyst) Regulations 2014, Registration No. INH100001690, BSE Enlistment No. 5114. The tracker sheet service is an extension and reflection of our research analysis and is in no way a portfolio advisory or buy/sell recommendation for you. The purpose of tracker sheet is to get a tentative performance snapshot on portfolio basis than on individual stock basis. It is basically a Performance measuring tool, similar to say an index.
The tracker sheet service is basically an information service and doesn’t take into account your personal financial situation or risk profile. Please consult your financial adviser before following or implementing the same partially or in totality.
The transactions mentioned are not the actual transactions but take into account the ending prices for the day and ~0.3% transaction charge.
There’s zero refund policy because as soon as you subscribe to the same you get access to the complete portfolio snapshot.
Research Analyst Details
Name: Ekansh Mittal Email Id: [email protected] Ph: +91 727 5050062
Analyst Certification: The Analyst certify (ies) that the views expressed herein accurately reflect his (their) personal view(s) about the subject security (ies) and issuer(s) and that no part of his (their) compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report.
Disclaimer: www.katalystwealth.com (here in referred to as Katalyst Wealth) is the domain owned by Ekansh Mittal. Mr. Ekansh Mittal is the sole proprietor of Mittal Consulting and offers independent equity research services to retail clients on subscription basis. SEBI (Research Analyst) Regulations 2014, Registration No. INH100001690, BSE Enlistment No. 5114.
Address – 7, Panch Ratan, 7/128, Swaroop Nagar, Kanpur – 208002, Contact No. – +91-7275050062
Compliance Officer – Mr. Ekansh Mittal, +91-9818866676, [email protected]
Grievance Redressal – Mittal Consulting, [email protected], +91-9818866676, +91-7275050062
“Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors”.
Performance numbers do not include the impact of transaction fee and other related costs.
Past performance does not guarantee future returns.
“Investment in securities market are subject to market risks. Read all the related documents carefully before investing.”
The views expressed are based solely on information available publicly and believed to be true.
Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision
A graph of daily closing prices of securities is available at www.bseindia.com (Choose a company from the list on the browser and select the “three years” period in the price chart
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. Ekansh Mittal/Mittal Consulting/Katalyst Wealth is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Ekansh Mittal or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither Ekansh Mittal, nor its employees, agents nor representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. Ekansh Mittal/Mittal Consulting or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement.
The recipients of this report should rely on their own investigations. Ekansh Mittal/Mittal Consulting and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. Mittal Consulting has incorporated adequate disclosures in this document. This should, however, not be treated as endorsement of the views expressed in the report.
We submit that no material disciplinary action has been taken on Ekansh Mittal by any regulatory authority impacting Equity Research Analysis.
Disclosure (SEBI RA Regulations)
Whether the research analyst or research entity or his associate or his relative has any financial interest in the subject company/companies and the nature of such financial interest – Yes, investment in Manappuram Finance, Carysil, Shemaroo, Fiem Industries, Insecticides India, Shree Pushkar, Kaveri Seed, LT Foods, Dollar Industries, Sharda Cropchem, Time Technoplast, IOLCP, Chaman Lal Setia, Ultramarine Pigment, 20 Microns, Valiant Organics and Repco Home Finance.
Whether the research analyst or research entity or his associates or his relatives have actual/beneficial ownership of 1% or more securities of the subject company (at the end of the month immediately preceding the date of publication of the research report or date of the public appearance) – No
Whether the research analyst or research entity or his associate or his relative has any other material conflict of interest at the time of publication of the research report or at the time of public appearance – No
Whether it or its associates have received any compensation from the subject company in the past twelve months – No
Whether it or its associates have managed or co-managed public offering of securities for the subject company in the past 12 months – No
Whether it or its associates have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months – No
Whether it or its associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months – No
Whether the subject company is or was a client during twelve months preceding the date of distribution of the research report and the types of services provided – No
Whether the research analyst has served as an officer, director or employee of the subject company – No
Whether the research analyst or research entity has been engaged in market making activity for the subject company – No